Biotechnology

Biotechnology·Financial Investment·Future·Healthcare·NASDAQ·News·Reviews·Sustainability

Why MoonLake Immunotherapeutics Could Be the Next Big Bet in Healthcare

MoonLake Immunotherapeutics (NASDAQ: MLTX) emerges as a key player in the biopharmaceutical sector, attracting investor attention amid rising US healthcare costs. The healthcare sector now constitutes 17.6% of the US economy, with companies like MoonLake poised to reshape the landscape. MoonLake’s innovative

February 20, 2025

Biotechnology·Financial Growth·Innovation·News·Reviews·Sustainability

Exact Sciences Rides a Wave of Innovation and Financial Growth into 2025

Exact Sciences delivered over 4.6 million cancer test results in 2024, showcasing significant growth and innovation in cancer diagnostics. Key achievements include FDA approval for Cologuard Plus and the introduction of Oncodetect, enhancing colon cancer screening and molecular residual disease detection. The

February 20, 2025